Chemokine-Based Therapeutics for the Treatment of Inflammatory and Fibrotic Convergent Pathways in COVID-19

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the SARS-CoV-2 betacoronavirus and has taken over 761,426 American lives as of the date of publication and will likely result in long-term, if not permanent, tissue damage for countless patients. COVID-19 presents with diverse an...

Descripción completa

Detalles Bibliográficos
Autores principales: Julian, Dana R., Kazakoff, Megan A., Patel, Akhil, Jaynes, Jesse, Willis, Monte S., Yates, Cecelia C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Wound Healing and Tissue Repair (Cc Yates, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651461/
https://www.ncbi.nlm.nih.gov/pubmed/34900402
http://dx.doi.org/10.1007/s40139-021-00226-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651461/
https://www.ncbi.nlm.nih.gov/pubmed/34900402
http://dx.doi.org/10.1007/s40139-021-00226-0

Ejemplares similares